Multiple Myeloma Treatment at John Theurer Cancer Center in New Jersey

You will have access to the latest medical therapies for multiple myeloma, including medications developed through our research, such as thalidomide, lenalidomide, pomalidomide, bortezomib, carfilzomib, elotuzumab, daratumumab, and more.

John Theurer Cancer Center is one of the few centers worldwide offering CAR T-cell therapy for multiple myeloma. This breakthrough immunotherapy uses your own immune cells to target and destroy cancer cells. Patients who had relapsed after prior treatments have achieved long-term remission through CAR T-cell therapy. Learn more about CAR T-Cell therapy. 

Our team has pioneered the use of advanced immunotherapy for multiple myeloma, including T-cell engagers, antibody-drug conjugates, and checkpoint inhibitors. These therapies activate your immune system to find and eliminate cancer cells.

If you have been diagnosed with smoldering multiple myeloma or MGUS (monoclonal gammopathy of undetermined significance), we offer personalized surveillance to monitor your condition. Our team will guide you on whether treatment is necessary and provide access to clinical trials focused on early detection and optimal treatment timing.

At John Theurer Cancer Center, we have one of the largest blood and marrow stem cell programs in the country, performing over 250 transplants annually for multiple myeloma. Our center specializes in autologous and allogeneic stem cell transplants, with a focus on reducing complications and lowering the risk of cancer recurrence. We are global leaders in combining checkpoint inhibitors with stem cell transplantation, providing patients with the most advanced care available. Our Blood and Marrow Stem Cell Transplant Program.

John Theurer Cancer Center has one of the largest and most experienced myeloma programs in the world. Our dedicated team of specialists are leaders in myeloma research and provide personalized care using a precision medicine approach. This gives our patients access to advanced treatment options, including clinical trials, that are not available elsewhere.

Our approach begins with a highly accurate diagnosis using specialized imaging, molecular analysis, and genetic testing. Our doctors, who published the first complete genomic portrait of this cancer, use this detailed information to tailor treatments specifically to your type of myeloma, offering the best possible chance for success.

We offer several breakthrough treatments. We are one of the few centers worldwide offering CAR T-cell therapy, which uses your own immune cells to fight cancer. We also pioneered the use of advanced immunotherapies like T-cell engagers and antibody-drug conjugates. Additionally, you will have access to the latest medical therapies, many developed through our own research.

If you have been diagnosed with a pre-myeloma condition like MGUS or smoldering multiple myeloma, we offer personalized surveillance to closely monitor your condition. Our expert team will guide you on whether treatment is necessary and provide access to clinical trials focused on early detection and determining the optimal time to begin treatment.

We have one of the largest and most experienced blood and marrow stem cell programs in the country, performing over 250 transplants for multiple myeloma annually. We are global leaders in this area and were the first in the world to combine checkpoint inhibitors with stem cell transplants, a technique designed to empower the immune system and reduce the risk of cancer recurrence.